Latest News

Cutaneous lupus: Switching antimalarials can delay immunosuppressive therapy


 

EXPERT ANALYSIS FROM ICCLE 2018


In patients with highly active skin disease at baseline, Dr. Fernandez said he will sometimes start hydroxychloroquine higher than 400 mg initially but will bring patients back down to 400 mg after a few months.

Dr. Fernandez had no relevant disclosures.

Pages

Recommended Reading

VIDEO: Dual studies seek answers in isolated skin vasculitis
MDedge Dermatology
VIDEO: Let clinical scenario, not imaging, guide sarcoidosis treatment
MDedge Dermatology
VIDEO: Skin exam crucial in rheumatic diseases, expert says
MDedge Dermatology
VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Dermatology
New agents may bring hope for SLE patients
MDedge Dermatology
Caution crucial for stem cell transplant in scleroderma, despite potential interest
MDedge Dermatology
Don’t trust interface dermatitis to diagnose dermatomyositis
MDedge Dermatology
Median time to progression from discoid to systemic lupus may be less than a year
MDedge Dermatology
Timely dermatomyositis diagnosis, treatment remain elusive
MDedge Dermatology
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Dermatology